Form 8.3 - STERIS CORPORATION

LONDON--()--

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)   Full name of discloser:   Barclays PLC.
     
(b) Owner or controller of interest and short
  positions disclosed, if different from 1(a):  
(c) Name of offeror/offeree in relation to whose STERIS CORPORATION
  relevant securities this form relates:  
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
  offeror/offeree:  
(e) Date position held/dealing undertaken: 07 October 2015
(f) In addition to the company in 1(c) above, is the discloser making YES:
  disclosures in respect of any other party to the offer? SYNERGY HEALTH PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:   ORD
  Interests   Short Positions
    Number   (%) Number   (%)
(1) Relevant securities owned
and/or controlled: 2,511 0.00% 286,611 0.48%
           
(2) Cash-settled derivatives:
284,112 0.47% 0 0.00%
           
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
           
 
TOTAL: 286,623 0.48% 286,611 0.48%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant   Purchase/sale   Number of   Price per unit
security   securities  
ORD Purchase 2 66.6500 USD
ORD Purchase 91 66.1496 USD
ORD Purchase 185 65.8608 USD
ORD Purchase 300 65.7733 USD
ORD Purchase 400 65.6325 USD
ORD Purchase 407 66.1561 USD
ORD Purchase 448 66.1143 USD
ORD Purchase 500 65.7228 USD
ORD Purchase 515 65.7437 USD
ORD Purchase 1,200 65.7400 USD
ORD Purchase 2,005 65.6407 USD
ORD Purchase 2,300 65.9843 USD
ORD Purchase 3,600 66.0165 USD
ORD Purchase 5,632 66.0866 USD
ORD Purchase 6,600 65.6222 USD
ORD Purchase 9,724 66.0052 USD
ORD Purchase 9,926 66.0051 USD
ORD Purchase 10,108 65.9637 USD
ORD Purchase 11,000 65.7815 USD
ORD Sale 10 65.6100 USD
ORD Sale 80 65.6300 USD
ORD Sale 100 66.0800 USD
ORD Sale 100 65.6700 USD
ORD Sale 100 65.6400 USD
ORD Sale 100 66.3800 USD
ORD Sale 100 65.8500 USD
ORD Sale 100 65.9000 USD
ORD Sale 165 66.1109 USD
ORD Sale 200 66.4000 USD
ORD Sale 200 65.7750 USD
ORD Sale 237 65.9881 USD
ORD Sale 296 65.9264 USD
ORD Sale 300 65.7666 USD
ORD Sale 300 65.7400 USD
ORD Sale 300 66.0633 USD
ORD Sale 300 65.7366 USD
ORD Sale 300 66.0213 USD
ORD Sale 300 65.8083 USD
ORD Sale 310 65.6000 USD
ORD Sale 394 66.1780 USD
ORD Sale 400 65.8050 USD
ORD Sale 400 65.7075 USD
ORD Sale 400 65.7825 USD
ORD Sale 472 65.8202 USD
ORD Sale 557 65.7082 USD
ORD Sale 602 65.9408 USD
ORD Sale 800 65.7018 USD
ORD Sale 800 65.7902 USD
ORD Sale 1,160 66.5746 USD
ORD Sale 1,200 65.5916 USD
ORD Sale 1,246 66.1239 USD
ORD Sale 1,684 66.0906 USD
ORD Sale 1,800 65.7242 USD
ORD Sale 2,100 65.9692 USD
ORD Sale 2,205 65.6733 USD
ORD Sale 2,300 66.0195 USD
ORD Sale 2,510 65.9971 USD
ORD Sale 3,600 66.0165 USD
ORD Sale 4,488 66.0713 USD
ORD Sale 8,600 65.7140 USD
ORD Sale 9,825 66.0051 USD
ORD Sale 13,500 65.8383 USD

(b) Cash-settled derivative transactions

Class of relevant security   Product description

e.g. CFD

  Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

  Number of reference securities   Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type

e.g. American, European etc.

  Expiry date   Option money paid/ received per unit

(ii) Exercise

Class of relevant security   Product description

e.g. call option

  Exercising/ exercised against   Number of securities   Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security   Nature of dealing

e.g. subscription, conversion

  Details   Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?   NO
Date of disclosure: 8 Oct 2015
Contact name: Jay Supaya
Telephone number: 020 7773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Short Name: BARCLAYS PLC
Category Code: RET
Sequence Number: 488642
Time of Receipt (offset from UTC): 20151008T122448+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC